How much funding has Chicago Biosolutions, Inc. raised?

Chicago Biosolutions, Inc. has raised $999K in total funding, most recently a Grant round.

Who are Chicago Biosolutions, Inc.'s investors?

Chicago Biosolutions, Inc.'s investors include National Institutes of Health.

When was Chicago Biosolutions, Inc. founded?

Chicago Biosolutions, Inc. was founded in 2016.

Where is Chicago Biosolutions, Inc. headquartered?

Chicago Biosolutions, Inc. is headquartered in Chicago, Illinois, United States.

What industry is Chicago Biosolutions, Inc. in?

Chicago Biosolutions, Inc. operates in Biotech, Healthcare.

How many employees does Chicago Biosolutions, Inc. have?

Chicago Biosolutions, Inc. has 1-10 employees.

Chicago Biosolutions, Inc.

ABOUT US | chicago-biosolutions

Chicago, United States · Founded 2016 · $999K raised

Biotech

Healthcare

Headquarters: Chicago, Illinois
Employees: 1–10
Founded: 2016
Business Model: B2G

Website: chicagobiosolutions.com
Total Funding: $999K
Last Round: $999K GrantJan 2024
Rounds: 1

About

Chicago BioSolutions, Inc. is a biotech company focused on early drug discovery and development of small molecule antiviral therapeutics against emerging viruses including filovirus (Ebola, Marburg), influenza, henipavirus, and SARS-CoV-2. The company's multidisciplinary team has expertise in medicinal chemistry, computational science, virology, and immunology. Research is conducted in collaboration with academic institutions and is primarily funded by NIH and CDC SBIR/STTR grants.

Summary

Chicago Biosolutions, Inc. is a Biotech company based in Chicago, United States, founded in 2016. It has raised $999K in total across 1 round, most recently a $999K Grant round in Jan 2024. Investors include National Institutes of Health.

X (Twitter)